Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas
Authors:
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 26 (2) , 390-403
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 CA193556)
- American Philosophical Society
- NIH (F32 CA210409)
- NCI
- Association for Academic Surgery
This publication has 33 references indexed in Scilit:
- Folate Receptor in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: Potential Target for Folate-Linked Therapeutic AgentsArchives of Pathology & Laboratory Medicine, 2013
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsNature Medicine, 2011
- Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection studyJournal of Neurosurgery, 2011
- Synthesis and Biological Analysis of Prostate-Specific Membrane Antigen-Targeted Anticancer ProdrugsJournal of Medicinal Chemistry, 2010
- Folate-Targeted Therapies for CancerJournal of Medicinal Chemistry, 2010
- Local recurrence after surgery for early stage lung cancerCancer, 2009
- Is palpation of the nonresected pulmonary lobe(s) required for patients with non–small cell lung cancer? A prospective studyThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnalytical Biochemistry, 2005
- Cell and tissue autofluorescence research and diagnostic applications2005
- Folate receptor-targeted drugs for cancer and inflammatory diseasesAdvanced Drug Delivery Reviews, 2004